Immatics (NASDAQ:IMTXW) Stock, Quote.Headers.trade-ideas

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Immatics NV

Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAT#NASDAQ">HCAT</a>) with a Overweight and lowers the price target from $13 to $10.

News

Price Target

Analyst Ratings

HCAT

Wells Fargo Maintains Overweight on Health Catalyst, Lowers Price Target to $10

HYLN

Electrigen Will Collaborate With Hyliion, On A Project Aimed At Reducing Methane Emissions In The Oil And Gas Sector. Hyliion Has Been Awarded A $6M  Grant From The U.S. Department Of Energy's Methane Emissions Reduction Program

Wells Fargo analyst Michael Kaye maintains OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) with a Equal-Weight and raises the price target from $52 to $57.

Wells Fargo Maintains Equal-Weight on OneMain Holdings, Raises Price Target to $57

Bank of New York Mellon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) short percent of float has fallen 9.09% since its last report. The company recently reported that it has 8.70 million shares sold short, which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Bank of New York Mellon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737483321_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bank of New York Mellon has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Bank of New York Mellon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bank of New York Mellon's peer group average for short interest as a percentage of float is 3.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(BK) - Analyzing Bank of New York Mellon's Short Interest

Innodata's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NYSE">INOD</a>) short percent of float has risen 13.94% since its last report. The company recently reported that it has 3.85 million shares sold short, which is 14.22% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Innodata Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737483316_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Innodata has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Innodata's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Innodata's peer group average for short interest as a percentage of float is 3.24%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

INOD

How Is The Market Feeling About Innodata?

Intapp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NYSE">INTA</a>) short percent of float has risen 4.19% since its last report. The company recently reported that it has 3.09 million shares sold short, which is 9.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intapp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737483311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intapp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intapp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intapp's peer group average for short interest as a percentage of float is 9.55%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

INTA

(INTA) - Analyzing Intapp's Short Interest

UBS analyst Timothy Arcuri maintains Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Neutral and lowers the price target from $26 to $23.

INTC

UBS Maintains Neutral on Intel, Lowers Price Target to $23

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) active Investigational <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43093925/atara-biotherapeutics-provides-update-on-clinical-programs-related-to-ebvallo-tabelecleucel-and-at" rel="noreferrer noopener">New Drug (IND) applications</a>.
These INDs include the EBVALLO&nbsp;(tabelecleucel) program for patients two years of age and older with Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), as well as ATA3219, a CAR-T therapy for non-Hodgkin&#8217;s lymphoma and systemic lupus erythematosus.
Specifically, identified subjects currently enrolled in the clinical studies who have the potential to derive clinical benefit may continue to receive treatment.
Screening and enrollment of new participants in both programs have been paused.
The clinical hold for EBVALLO is directly linked to inadequately addressed GMP compliance issues identified during the pre-license inspection of the third-party manufacturing facility referenced in the Complete Response Letter (CRL) for EBVALLO that was <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43026975/atara-biotherapeutics-provides-regulatory-and-business-update-on-ebvallotm-tabelecleucel" rel="noreferrer noopener">announced last week</a>.
While the ATA3219 drug product is manufactured at a separate, fully compliant GMP-certified facility, the compliance issues at the same third-party facility referenced in the CRL affect the starting materials used in its production.
These issues, which underlie both the CRL and the clinical hold, are specific to the referenced third-party manufacturing facility and do not affect Atara&#8217;s second third-party manufacturer, FUJIFILM Diosynth Biotechnologies (FDB) facility in Thousand Oaks, California.
The FDB facility remains a critical component of Atara&#8217;s long-term manufacturing strategy for both assets.
Last week, Atara engaged a financial advisor to support the assessment of opportunities to advance and realize value from Atara&#8217;s CAR-T assets.
Atara says it remains eligible to receive a $60 million milestone payment from Pierre Fabre upon FDA approval of the EBVALLO BLA, as well as significant double-digit tiered royalties as a percentage of net sales and milestones related to EBVALLO&#8217;s commercial sales.
The company added that if a strategic resolution is not reached to provide funding for its CAR-T development programs in the first quarter of 2025, Atara plans to suspend all CAR-T activities and significantly reduce company expenses and activities to only those that support the approval of EBVALLO, including through a near-term progressive transfer of all operational activities related to EBVALLO to Pierre Fabre.
Atara has entered into a non-binding term sheet with Redmile Group to provide up to $15 million in funding through an equity line of credit.
Price Action: ATRA stock is down 4.09% at $6.302 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43098271/canoo-files-bankruptcy-stock-falls-nasa-walmart-dod-usps" target="_blank" rel="noreferrer noopener">EV Startup Canoo Files For Bankruptcy After NASA, USPS, Walmart Partnerships Bear Little Fruit</a></li>
</ul>
Photo via Shutterstock.

Biotech

Health Care

Movers

General

ATRA

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

UBS analyst Timothy Arcuri maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Neutral and raises the price target from $665 to $780.

KLAC

UBS Maintains Neutral on KLA, Raises Price Target to $780

Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) is upset about U.S. President Donald Trump&#8216;s proposed tariffs <a href="https://www.benzinga.com/topic/tariffs">on imports from Mexico</a>.
The Wolfsburg, Germany-based car manufacturer &#8220;is concerned about the harmful economic impact that proposed tariffs by the U.S. administration will have on American consumers and the international automotive industry,&#8221; a Volkswagen spokesperson told Reuters.
<a href="https://www.benzinga.com/24/11/42178994/trump-says-he-will-impose-25-tariffs-on-canada-mexico-on-first-day-of-office-and-extra-tariffs-on-china-until-they-pay-attention">The 25% tariff</a>, set to be enforced by Feb. 1, could significantly impact Volkswagen, which runs one of its major plants in Puebla, Mexico.
The German automaker cautioned that these tariffs could harm both U.S. consumers and the global automotive industry, according to a report from Reuters.
According to data from Edmunds, as <a href="https://www.wsj.com/business/autos/trump-tariff-plan-affordable-car-price-increase-1f3d4687?mod=hp_lead_pos2">reported</a> by the Wall Street Journal, approximately one-third of all cars under $30,000 in the U.S. are <a href="https://www.benzinga.com/government/regulations/24/12/42688941/are-us-vehicles-under-30000-a-thing-of-the-past-trumps-mexico-tariff-plans-could-change-auto-market">currently manufactured in Mexico</a>. This represents an increase from about one-fifth of such vehicles a decade ago.
It&#8217;s no wonder Mexican President Claudia Sheinbaum has warned Trump that a trade war is not in his best interest, citing how the automakers that will suffer are based in the U.S. and that Mexico could respond with its own protectionist moves.
"One tariff will be followed by another in response, and so on until we put common companies at risk," Sheinbaum said at a press conference in November per <a href="https://www.bloomberg.com/news/articles/2024-11-26/mexico-hints-at-retaliation-after-trump-threatens-steep-tariffs?srnd=homepage-americas">Bloomberg</a>. "The main exporters from Mexico to the US are General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), and Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), which arrived 80 years ago. Why put in place a tariff that puts them at risk?"
Trump argues that his economic strategy will restore American manufacturing and revamp the<a href="https://www.benzinga.com/government/regulations/25/01/43086509/trump-unleashes-executive-orders-on-border-security-oil-drilling-domestic-manufacturing-in-first-acts-as-president"> nation's trade system</a>.
Also Read: <a href="https://www.benzinga.com/news/25/01/43023778/gm-vianode-strike-multi-billion-anode-graphite-supply-deal-details">GM, Vianode Strike Multi-Billion Anode Graphite Supply Deal: Details</a>
He promised to shift the financial burden from U.S. taxpayers to foreign competitors, stating, &#8220;Instead of taxing our citizens to enrich other countries, we will tariff and tax foreign countries to enrich our citizens.&#8221;
The effects would extend beyond new vehicles, and affect prices of replacement components such as engines, transmissions, and tires also facing price hikes.
GM, Ford and Stellantis rely significantly on Mexican factories for these parts, meaning the higher costs would eventually be <a href="https://www.benzinga.com/startups/24/12/42344194/these-products-will-likely-see-price-hikes-due-to-trumps-tariffs-on-canada-and-mexico-2">passed on to U.S. consumers</a>.
Stellantis chair John Elkann, who recently visited Trump as part of a wider effort to connect with the newly-elected government, promised to adapt to the U.S. market under the new administration, per Reuters.
Stellantis also maintains two plants in Mexico, in Saltillo and Toluca.
Price Action: VWAGY shares are trading higher by 2.66% at $10.03 on the last check Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43027582/toyota-subsidiary-agrees-to-16b-settlement-over-emission-data-fraud">Toyota Subsidiary Agrees To $1.6B Settlement Over Emission Data Fraud</a></li>
</ul>
Image: Shutterstock

Politics

STLA

VWAGY

Volkswagen 'Concerned' Over Trump Tariffs: Will Automakers Pass Costs To US Consumers?

WIIM

DELL

NVDA

ORCL

Shares of AI tech companies are trading higher after reports that President Trump will announce private sector AI infrastructure investment. OpenAI, Softbank and Oracle are planning a joint venture called Stargate and are expected to commit $100 billion initially and pour up to $500 billion into Stargate over the next four years.

Brian Moynihan, CEO of Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), on Tuesday indicated a willingness for the U.S. banking sector to fully incorporate cryptocurrencies <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42798512/cryptocurrency-exchanges-will-have-banking-functionality-by-2027">into payment systems</a>.
This comes with a crucial condition: clear regulatory approval. 
What Happened: Speaking at the World Economic Forum, Moynihan <a href="https://www.cnbc.com/2025/01/21/bank-of-america-ceo-financial-industry-will-embrace-crypto-if-regulators-allow-it.html">responded</a> to questions about the potential impact of President Donald Trump&#8216;s positive views on digital currencies.
This suggests a significant shift in tone, as previously, many big banks had shied away from integrating crypto payments at the consumer level. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">Meme Coin Supercycle? Dogecoin, Trump, Bonk Futures ETF Applications Filed</a>
However, Moynihan&#8217;s comments do not suggest that Bank of America, or the banking sector as a whole, currently see cryptocurrency as an investment vehicle, but rather solely as a transactional tool.
Moynihan explained that if regulators establish a framework that enables secure and legitimate cryptocurrency transactions, traditional banks would likely become heavily involved in facilitating them. 
He pointed out that these transactions could potentially operate in much the same way as existing payment systems. 
The implication here is that crypto payments might become as commonplace as credit card transactions. 
Bank of America, he further noted, has been actively researching blockchain technology, demonstrating their readiness to enter the space if and when regulations are approved. 
This suggests a level of readiness, rather than a speculation or projection. 
Moynihan drew a distinction between crypto&#8217;s use as a payment method and it&#8217;s possible uses as an investment, stating that these are separate concerns. 
This is important because while banks have been very active in some crypto areas like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETFs, they have so far been resistant to the idea of everyday payments.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43104549/microstrategy-buys-11000-bitcoin-total-holdings-reach-461000-btc">MicroStrategy Buys 11,000 Bitcoin, Total Holdings Reach 461,000 BTC</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bank Of America CEO Signals Crypto Payment Acceptance, Pending Regulatory Green Light

Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Dollar Gen, presenting an average target of $89.07, a high estimate of $104.00, and a low estimate of $80.00. This current average represents a 8.65% decrease from the previous average price target of $97.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1737482456_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Dollar Gen. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Karen Short</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$96.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Koji Ikeda</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$95.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Kelly Bania</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$84.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$104.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$83.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$88.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$95.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$90.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Kelly Bania</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$80.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Corey Tarlowe</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dollar Gen. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Dollar Gen compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Dollar Gen's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Dollar Gen's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dollar Gen analyst ratings.</a>
<h2>About Dollar Gen</h2>
With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged and perishable food, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.
<h3>Financial Insights: Dollar Gen</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Dollar Gen's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.05% as of 31 October, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Dollar Gen's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Dollar Gen's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.69%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Dollar Gen's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.62%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.39, Dollar Gen faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Dollar Gen Through The Eyes Of 14 Analysts

Throughout the last three months, 7 analysts have evaluated Bread Finl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Bread Finl Hldgs, revealing an average target of $61.0, a high estimate of $88.00, and a low estimate of $34.00. Witnessing a positive shift, the current average has risen by 10.33% from the previous average price target of $55.29.
<img src="https://www.benzinga.com/files/images/story/2025/1737482449_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Bread Finl Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$87.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$58.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$54.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Bill Ryan</td>
<td>Seaport Global</td>
<td>Lowers</td>
<td>Buy</td>
<td>$56.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Moshe Orenbuch</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$34.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Bread Finl Hldgs. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Bread Finl Hldgs compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Bread Finl Hldgs's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Bread Finl Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BFH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bread Finl Hldgs analyst ratings.</a>
<h2>Get to Know Bread Finl Hldgs Better</h2>
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains minority interest in its recently spun-off LoyaltyOne division, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
<h3>Financial Insights: Bread Finl Hldgs</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Bread Finl Hldgs's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -4.66%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Bread Finl Hldgs's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.2%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Bread Finl Hldgs's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.06%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Bread Finl Hldgs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.01%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Bread Finl Hldgs's debt-to-equity ratio is below the industry average at 1.47, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Bread Finl Hldgs Stock: Analyst Perspectives (7 Ratings)

Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.25, a high estimate of $82.00, and a low estimate of $77.00. This current average reflects an increase of 6.38% from the previous average price target of $74.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1737482440_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Independent Bank. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher O'Connell</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Steve Moss</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$78.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Christopher O'Connell</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$82.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Christopher O'Connell</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$77.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Independent Bank. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Independent Bank compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Independent Bank's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Independent Bank's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INDB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Independent Bank analyst ratings.</a>
<h2>Discovering Independent Bank: A Closer Look</h2>
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers, and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
<h3>Independent Bank's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Independent Bank's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -3.57%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Independent Bank's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 24.59%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Independent Bank's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.46%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Independent Bank's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.22%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Independent Bank's debt-to-equity ratio is below the industry average at 0.22, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INDB

Demystifying Independent Bank: Insights From 4 Analyst Reviews

Investors with a lot of money to spend have taken a bearish stance on RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RTX, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for RTX.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 50%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $71,784, and 8 are calls, for a total amount of $334,729.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $112.0 to $130.0 for RTX during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of RTX stands at 1883.33, with a total volume reaching 1,669.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in RTX, situated within the strike price corridor from $112.0 to $130.0, throughout the last 30 days.
<h3>RTX 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737482438_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$5.08</td>
<td>$125.00</td>
<td>$67.2K</td>
<td>4.3K</td>
<td align="right">157</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$7.25</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$120.00</td>
<td>$56.8K</td>
<td>1.4K</td>
<td align="right">94</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.35</td>
<td>$7.3</td>
<td>$7.35</td>
<td>$120.00</td>
<td>$52.1K</td>
<td>1.4K</td>
<td align="right">103</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$3.1</td>
<td>$2.9</td>
<td>$3.0</td>
<td>$125.00</td>
<td>$43.5K</td>
<td>4.1K</td>
<td align="right">24</td>
</tr>
<tr>
<td>RTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$1.92</td>
<td>$1.74</td>
<td>$1.74</td>
<td>$120.00</td>
<td>$37.5K</td>
<td>2.8K</td>
<td align="right">220</td>
</tr>
</tbody>
</table>

<h3>About RTX</h3>
RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace and to the defense market. The company operates in three segments: Collins Aerospace, a diversified aerospace supplier; Pratt &amp; Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.
In light of the recent options history for RTX, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is RTX Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,081,373, with RTX's price up by 3.53%, positioned at $125.38.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 7 days.</li>
</ul>
<h3>What The Experts Say On RTX</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $145.75.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Susquehanna has decided to maintain their Positive rating on RTX, which currently sits at a price target of $139. 
&#x2A; An analyst from Citigroup upgraded its action to Buy with a price target of $153. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on RTX with a target price of $151. 
&#x2A; An analyst from Deutsche Bank upgraded its action to Buy with a price target of $140. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest RTX options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Spotlight on RTX: Analyzing the Surge in Options Activity

America&#8217;s artificial intelligence boom is triggering an <a href="https://www.benzinga.com/24/12/42349552/is-the-mag-7s-ai-boom-supercharging-a-natural-gas-revolution">unexpected surge in natural gas power plant construction</a>, upending clean energy forecasts and culminating in Constellation Energy&#8217;s $27 billion acquisition of gas giant Calpine.
Energy consultancy Enverus projects that 80 new gas-fired plants will be built across the United States by 2030, adding 46 gigawatts of power capacity – equivalent to Norway&#8217;s entire electrical system, according to a report issued by the Financial Times. The expansion marks a 20% increase over the past five years&#8217; construction pace and reverses earlier predictions of declining gas capacity.
&#8220;Gas is actually growing faster now and in the medium term, than ever before,&#8221; Enverus research analyst Corianna Mah told the Financial Times.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Major tech companies <a href="https://www.benzinga.com/government/regulations/25/01/42865106/trump-vows-to-power-ai-boom-with-expanded-oil-drilling-need-double-the-electricity-at-least-that-we-have-right-now">are driving the fossil fuel renaissance</a>. Meta recently announced plans to power its $10 billion AI data center through Entergy&#8217;s $3.2 billion gas plant expansion. Once the facility comes online, the social media giant will become the utility&#8217;s largest customer.
The Department of Energy expects AI-related electricity demand from data centers to triple within three years. The surge caught even industry veterans off guard. &#8220;I wish I could&#8217;ve predicted it 18 months ago,&#8221; said Bill Newsom, CEO of turbine manufacturer Mitsubishi Power Americas, which now plans to boost production capacity by 50%.
Traditional energy companies are rushing to capitalize. ExxonMobil and Chevron are designing plants to supply AI data centers directly while utilities keep aging facilities running longer than planned. Wood Mackenzie has cut its 2035 forecast for gas plant retirements by 10%.
See Also: With 100+ historic trademark victories, this company holds IP for some of the highest-grossing characters in history. Now, they've propelled these icons into the future using next-gen patented AR, VR, and AI technology. <a href="https://www.benzinga.com/money/elf-labs-1">There&#8217;s now a limited window for investors to claim shares at just $2/share with $980 minimum—but the clock is ticking.</a>
The construction wave threatens the Biden administration&#8217;s climate goals, which target a 50% emissions cut by the decade&#8217;s end. According to data from energy think tank Ember cited by the Financial Times, U.S. gas plants released over one billion tons of carbon dioxide last year – their highest output on record.
While renewable energy development continues, industry leaders say current battery technology can&#8217;t match gas plants&#8217; reliability for power-hungry AI operations. &#8220;Your ability to serve that kind of load reliably is very limited with traditional renewables,&#8221; Matt Bulpitt, Entergy&#8217;s vice president of power development, said to Financial Times.
Texas, Tennessee and South Carolina led the gas expansion. None of the planned facilities will include carbon capture systems, equipment that would become mandatory in 2032 under Biden-era rules likely to face rollback under Trump&#8217;s second term.
Read Next:
<ul>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

'I Wish I Could've Predicted It': The $27 Billion Gas Deal Behind AI's Energy Appetite

In the last three months, 6 analysts have published ratings on LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $68.17, a high estimate of $78.00, and a low estimate of $58.00. Surpassing the previous average price target of $62.60, the current average has increased by 8.9%.
<img src="https://www.benzinga.com/files/images/story/2025/1737482432_0_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of LendingTree by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Grondahl</td>
<td>Northland Capital Markets</td>
<td>Announces</td>
<td>Outperform</td>
<td>$60.00</td>
<td>-</td>
</tr>
<tr>
<td>Jed Kelly</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Ryan Tomasello</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$73.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$67.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to LendingTree. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of LendingTree compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for LendingTree's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of LendingTree's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TREE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on LendingTree analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind LendingTree</h2>
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.
<h3>LendingTree: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: LendingTree's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 68.05%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: LendingTree's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -22.23%, the company may face hurdles in effective cost management.
Return on Equity (ROE): LendingTree's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -48.3%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): LendingTree's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -7.3%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 5.82, LendingTree faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TREE

6 Analysts Have This To Say About LendingTree

Investors with a lot of money to spend have taken a bearish stance on NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NEE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for NextEra Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 50%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $333,725, and 8 are calls, for a total amount of $553,754.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $57.5 to $100.0 for NextEra Energy during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for NextEra Energy options trades today is 489.71 with a total volume of 7,384.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for NextEra Energy's big money trades within a strike price range of $57.5 to $100.0 over the last 30 days.
<h3>NextEra Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737482432_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.35</td>
<td>$2.21</td>
<td>$2.31</td>
<td>$57.50</td>
<td>$231.0K</td>
<td>495</td>
<td>1.0K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$0.79</td>
<td>$0.72</td>
<td>$0.75</td>
<td>$77.50</td>
<td>$158.0K</td>
<td>2.6K</td>
<td>3.6K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.21</td>
<td>$2.2</td>
<td>$2.2</td>
<td>$72.00</td>
<td>$126.8K</td>
<td>0</td>
<td>575</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$29.35</td>
<td>$28.85</td>
<td>$29.35</td>
<td>$100.00</td>
<td>$102.7K</td>
<td>45</td>
<td>35</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$0.75</td>
<td>$0.72</td>
<td>$0.75</td>
<td>$77.50</td>
<td>$75.0K</td>
<td>2.6K</td>
<td>1.5K</td>
</tr>
</tbody>
</table>

<h3>About NextEra Energy</h3>
NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to nearly 6 million customer accounts in Florida and owns 34 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 34 GW of generation capacity, including natural gas, nuclear, wind, and solar.
In light of the recent options history for NextEra Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is NextEra Energy Standing Right Now?</h3>
<ul>
<li>With a trading volume of 4,662,056, the price of NEE is up by 0.6%, reaching $71.19.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 3 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for NextEra Energy, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

NextEra Energy's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RVPH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Reviva Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 9% bullish and 90%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $663,591, and 3 are calls, for a total amount of $83,209.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.0 to $5.0 for Reviva Pharmaceuticals during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Reviva Pharmaceuticals's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Reviva Pharmaceuticals's whale activity within a strike price range from $2.0 to $5.0 in the last 30 days. 
<h3>Reviva Pharmaceuticals Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737482427_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RVPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$3.3</td>
<td>$3.5</td>
<td>$5.00</td>
<td>$194.9K</td>
<td align="right">689</td>
<td>1.7K</td>
</tr>
<tr>
<td>RVPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$3.1</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$122.4K</td>
<td align="right">689</td>
<td>774</td>
</tr>
<tr>
<td>RVPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$2.9</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$115.2K</td>
<td align="right">689</td>
<td>374</td>
</tr>
<tr>
<td>RVPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.5</td>
<td>$3.1</td>
<td>$3.5</td>
<td>$5.00</td>
<td>$76.6K</td>
<td align="right">689</td>
<td>2.0K</td>
</tr>
<tr>
<td>RVPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.5</td>
<td>$2.7</td>
<td>$3.5</td>
<td>$5.00</td>
<td>$44.8K</td>
<td align="right">689</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Reviva Pharmaceuticals</h3>
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
<h3>Where Is Reviva Pharmaceuticals Standing Right Now?</h3>
<ul>
<li>With a volume of 2,226,838, the price of RVPH is up 4.52% at $1.85. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 83 days.</li>
</ul>
<h3>What The Experts Say On Reviva Pharmaceuticals</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $9.666666666666666.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from D. Boral Capital persists with their Buy rating on Reviva Pharmaceuticals, maintaining a target price of $15. 
&#x2A; Reflecting concerns, an analyst from Roth MKM lowers its rating to Buy with a new price target of $7. 
&#x2A; An analyst from Maxim Group has elevated its stance to Buy, setting a new price target at $7. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Reviva Pharmaceuticals with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Comments

Immatics

Immatics (IMTXW) Forecast

Immatics (NASDAQ:IMTXW) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga